Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY

ALNYLAM PHARMACEUTICALS, INC.

(ALNY)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
ETFs positionnés sur ALNYLAM PHARMACEUTICALS, IETFs et Trackers avec Trackinsight
ETFVar. 5jours PoidsRatingZone géographiqueCatégorie et Secteur
BMO Equal Weight U.S. Health Care H...0.10%1.98%Etats UnisActions - Santé
SPDR S&P Biotech ETF - USD-1.45%1.64%Etats UnisActions - Biotechnologie
IShares Morningstar Mid-Cap Growth ...-2.95%0.33%Etats UnisActions
Xtrackers MSCI USA Health Care - U...1.84%0.32%-Etats UnisActions - Santé
Deka MSCI USA MC - USD-2.86%0.32%Etats UnisActions
SPDR MSCI World Health Care - USD2.93%0.22%MondeActions - Santé
IShares MSCI USA Equal Weighted ETF...0.00%0.17%Etats UnisActions
Xtrackers Russell Midcap 1C - USD-5.37%0.15%Etats UnisActions
UBS (Irl) ETF plc - MSCI USA A-dis...0.36%0.05%Etats UnisActions
UBS (Irl) ETF plc - MSCI USA (USD)...-3.02%0.05%-Etats UnisActions
UBS (Irl) ETF plc - MSCI USA (USD)...-0.68%0.05%-Etats UnisActions
UBS (Irl) ETF plc - MSCI USA hedged...-4.25%0.05%Etats UnisActions
UBS (Irl) ETF plc - MSCI USA hedged...-4.25%0.05%Etats UnisActions
UBS (Irl) ETF plc - MSCI USA hedged...-3.25%0.05%Etats UnisActions
UBS ETF (IE) MSCI USA (hedged to G...-1.96%0.05%-Etats UnisActions
UBS ETF (IE) MSCI USA (hedged to G...-2.43%0.05%-Etats UnisActions
UBS ETF - MSCI USA A-dis - USD-2.17%0.05%Etats UnisActions
UBS ETF - MSCI USA (USD) A-UKdis -...-2.46%0.05%Etats UnisActions
Xtrackers MSCI USA 2C - EUR Hedged...-2.74%0.05%-Etats UnisActions
Xtrackers MSCI USA - USD-2.64%0.05%Etats UnisActions
1  2Suiv.



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique ALNYLAM PHARMACEUTICALS, INC.
Durée : Période :
Alnylam Pharmaceuticals, Inc. : Graphique analyse technique Alnylam Pharmaceuticals, Inc. | Zone bourse
Graphique plein écran
Evolution du Compte de Résultat
Consensus
Vente
Achat
Recommandation moyenne ACCUMULER
Nombre d'Analystes 23
Objectif de cours Moyen 138,35  $
Dernier Cours de Cloture 104,21  $
Ecart / Objectif Haut 91,9%
Ecart / Objectif Moyen 32,8%
Ecart / Objectif Bas -28,0%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapitalisation (M$)
ALNYLAM PHARMACEUTICALS, INC.-8.12%12 308
LONZA GROUP13.73%31 009
CELLTRION, INC.22.13%25 160
IQVIA HOLDINGS INC.-33.52%20 797
SEATTLE GENETICS, INC.1.97%19 875
INCYTE CORPORATION-11.74%15 874